NORTH CENTRAL RAILWAY has floated a tender for Inj. Human Pepilloma Quadrivalent Virus Vaccine. The project location is Allahabad, Uttar Pradesh, India. The reference number is 73T22- 23MDmedicineR and it is closing on 24 Jun 2022.
Suppliers can request Register free of cost to get the complete Tender details and download the document.
Procurement Summary
State : Uttar Pradesh
Summary : Inj. Human Pepilloma Quadrivalent Virus Vaccine
Deadline : 24 Jun 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 67807059
Document Ref. No. : 73T22- 23MDmedicineR
Competition : NCB
Financier : Self Financed
Purchaser Ownership : Public
Purchaser's Detail
Purchaser : NORTH CENTRAL RAILWAY Address: Central Hospital-ald-medical/north Central Rly
City: Allahabad
District: Allahabad
State: Uttar Pradesh
Pin: 211002
Tel/Fax: 91-532-2408106 Country: India Email: cmm@ncr.railnet.gov.in Website: http://www.ncr.indianrailways.gov.in/
Tender Details
Inj. Human Pepilloma Quadrivalent Virus Vaccine
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 0.00
Tender Closing Date Time : 24/06/2022 11:00
Tender Type : Limited - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : MED STORE
Inspection Agency : CONSIGNEE
Publishing Date / Time : 16/06/2022 11:40 Bidding to be Done on IREPS
Procure From Approved Sources : No
Approving Agency : Not Applicable